Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study
Schmieder, G.J., Draelos, Z.D., Pariser, D.M., Banfield, C., Cox, L., Hodge, M., Kieras, E., Parsons‐Rich, D., Menon, S., Salganik, M., Page, K., Peeva, E.
Published in British journal of dermatology (1951) (01.07.2018)
Published in British journal of dermatology (1951) (01.07.2018)
Get full text
Journal Article